7Schernthaner G, Gross JL, Rosenstock J, et al. Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Ad- equate Glyeemie Control With Mefformin Plus Sulfonylurea A 52 - week randomized trial[J]. Diabetes Care,2013,36(9) :2 508 - 2 515.
8Cefatu WT, Leiter LA, Yoon KH, et al. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA- SU): 52 week results from a randomised, double - blind, phase 3 non - inferiority trial [ J ]. The Lancet, 2013, 382(9 896) :941 - 950.
10Saito I, Kokubo Y, Yamagishi K, et al. Diabetes and the risk of coronary heart disease in the general Japanese population : the Japan Public Health Centerbased prospective (JPHC) study[J].Atherosclerosis, 2011,216(1):187-191.
